XOOMAR

Connect Biopharma Holdings (CNTB)

Connect Biopharma Holdings on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

3.9M

Short interest

settlement 2026-10-15

1.7

Days to cover

+0.7 days vs prior

51.7%

Short share of volume

2026-11-02

25

Fails to deliver

settlement 2026-10-13

Wed 11 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in CNTB is 3,857,756 shares, up 1,083,695 shares over the last month. Over the last 48 readings it ranged from 5,404 shares (31 March 2025) to 3,857,756 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 2.2M shares a day that is 1.7 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cntb" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-153,857,756+10.2%2,225,1131.73
2026-09-303,499,648+26.2%15,989,4061.00
2026-09-152,774,061+39.6%2,819,1071.00
2026-08-311,987,166+9.3%476,8994.17
2026-08-141,818,101-11.7%407,4294.46
2026-07-312,060,037-0.1%256,7938.02
2026-07-152,062,435+55.4%740,9642.78
2026-06-301,327,642+25.1%627,6412.12
2026-06-151,061,303-9.1%261,9544.05
2026-05-291,166,987+0.8%198,7635.87
2026-05-151,157,694+2.1%140,3478.25
2026-04-301,134,300+14.0%235,4114.82
2026-04-15994,618+65.4%486,3422.05
2026-03-31601,458+58.8%369,4481.63
2026-03-13378,698+24.4%147,3322.57
2026-02-27304,407+1.9%78,7503.87
2026-02-13298,818+4.7%89,0983.35
2026-01-30285,402+4.9%96,7872.95
2026-01-15272,167+11.1%54,9764.95
2025-12-31245,091+18.4%144,3381.70
2025-12-15206,940+121.0%160,6531.29
2025-11-2893,644+27.7%1,153,3091.00
2025-11-1473,308+7.9%200,9791.00
2025-10-3167,937+5.7%46,9751.45
2025-10-1564,298+452.7%108,7341.00
2025-09-3011,634-14.8%79,4511.00
2025-09-1513,656-53.8%183,5291.00
2025-08-2929,537-71.2%128,2161.00
2025-08-15102,420+204.6%139,3831.00
2025-07-3133,623-43.9%308,5441.00
2025-07-1559,941+110.9%196,5531.00
2025-06-3028,427+66.6%104,8501.00
2025-06-1317,062-72.2%83,0011.00
2025-05-3061,369-19.2%70,8801.00
2025-05-1575,924+56.5%77,2581.00
2025-04-3048,519-25.3%99,2301.00
2025-04-1564,978+1102.4%407,8431.00
2025-03-315,404-47.3%33,8281.00
2025-03-1410,250-78.0%18,9121.00
2025-02-2846,660+56.6%23,4291.99
2025-02-1429,790-4.9%19,3361.54
2025-01-3131,337-23.3%12,6502.48
2025-01-1540,847-44.6%16,6432.45
2024-12-3173,791-16.0%38,4081.92
2024-12-1387,829+53.6%37,5452.34
2024-11-2957,184-7.5%23,0752.48
2024-11-1561,794+110.2%39,5521.56
2024-10-3129,400-35.3%12,5152.35

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of CNTB volume is 51.7%, down 23.1 points over the last five sessions. Over the last 30 readings it ranged from 13.1% (30 October 2026) to 76.3% (29 October 2026). The latest reading is in line with the 30-session average of 51.8%, on 300K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-02155K300K51.7%1
2026-10-30149K1.1M13.1%700
2026-10-29105K138K76.3%0
2026-10-2856K154K36.1%0
2026-10-2797K197K49.2%0
2026-10-26502K671K74.9%336
2026-10-23124K209K59.5%3,424
2026-10-22419K723K58.0%92,670
2026-10-21587K994K59.1%78,896
2026-10-20110K223K49.2%2,985
2026-10-19324K582K55.7%0
2026-10-16113K227K49.6%0
2026-10-15615K921K66.8%0
2026-10-14410K673K60.9%4,358
2026-10-13477K1.1M42.0%13,062
2026-10-12568K788K72.1%0
2026-10-09304K566K53.6%0
2026-10-08341K644K53.0%0
2026-10-07145K493K29.4%0
2026-10-06313K1.1M28.6%0
2026-10-05209K719K29.0%365
2026-10-021.3M2.4M53.2%152,075
2026-10-012.7M4.7M56.7%75,461
2026-09-3024.9M42.9M58.1%201,558
2026-09-29414K839K49.4%0
2026-09-28282K540K52.1%0
2026-09-25254K488K52.1%0
2026-09-24353K486K72.8%34,941
2026-09-23363K653K55.6%5,949
2026-09-22209K566K36.9%100

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 13 October 2026, the fails-to-deliver balance in CNTB is 25 shares, down 20,373 shares over the last settlement date. Over the last 30 readings it ranged from 25 shares (13 October 2026) to 510,315 shares (1 October 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-1325$0.91$23
2026-10-0920,398$0.88$18K
2026-10-0812,374$0.94$12K
2026-10-0712,340$0.91$11K
2026-10-051,467$0.93$1K
2026-10-01510,315$1.10$561K
2026-09-242,450$1.07$3K
2026-09-1656,445$1.17$66K
2026-09-152,175$1.73$4K
2026-09-11311$2.06$641
2026-09-042,491$1.93$5K
2026-08-3128$2.23$62
2026-08-2752$2.33$121
2026-08-1929$2.43$70
2026-08-11660$2.15$1K
2026-08-101,447$2.21$3K
2026-08-0673$2.18$159
2026-08-042,604$1.97$5K
2026-07-15105$2.36$248
2026-07-142,011$2.26$5K
2026-07-13614$2.51$2K
2026-07-104,500$2.66$12K
2026-07-0913,500$2.22$30K
2026-07-083,687$2.21$8K
2026-07-01184$2.38$438
2026-06-293,480$2.19$8K
2026-06-251,775$2.12$4K
2026-06-246,257$2.09$13K
2026-06-23157,006$1.99$312K
2026-06-226,649$2.00$13K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for CNTB in the last 90 days. The most recent filings are listed below. Latest filing: LIU JEAN I (Director) on 2026-09-30.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-09-30LIU JEAN IDirectorGrant9K$0.00$021K
2026-09-30Xanthopoulos Kleanthis GabrielDirectorGrant5K$0.00$092K
2026-06-30Xanthopoulos Kleanthis GabrielDirectorGrant4K$0.00$087K
2026-06-30LIU JEAN IDirectorGrant7K$0.00$012K
2026-05-29Huang JamesDirectorBuy150K$2.48$372K13.3M
2026-03-31Huang JamesDirectorBuy1.2M$3.45$4.0M13.2M
2026-03-31Xanthopoulos Kleanthis GabrielDirectorGrant3K$0.00$083K
2026-03-31LIU JEAN IDirectorGrant5K$0.00$05K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

4 Form 144 notices on file for CNTB worth $9.6M at the prices reported; 0 in the last 90 days worth $0. Latest: Panacea Innovation Limited filed on 2025-11-24 to sell 2,000,000 shares ($6.0M) from 2025-11-24.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2025-11-24Panacea Innovation Limited10% Owner2.0M$6.0M3.578%2025-11-24Jefferies Financial Group Inc.
2025-11-21Wei Zheng10% Stockholder650K$2.1M1.163%2025-11-21Charles Schwab & Co
2025-11-18BioFortune Inc10% Stockholder500K$1.2M0.900%2025-11-18Tiger Brokers (Singappre) Pte. Ltd.
2025-10-01Wei Zheng10% Stockholder200K$306K0.359%2025-10-01Charles Schwab & Co

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

11 holders report 5% or more of CNTB in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is James Huang at 21.2% of the class (13,160,000 shares), filed 2026-04-01 for an event on 2026-03-31.

FiledFormHolderSharesOf classEvent
2026-10-0613GBraden M Leonardindividual4.3M6.8%2026-09-30
2026-10-0613GBML Investment Partners, L.P.partnership3.9M6.1%2026-09-30
2026-08-1413G/Ano. 6Wei Zhengindividual2.5M4.0%2026-06-30
2026-08-1413G/Ano. 1Ikarian Capital, LLCinvestment adviser4.3M6.9%2026-06-30
2026-08-1413G/Ano. 1Neil Shahrestaniindividual, parent holding company4.3M6.9%2026-06-30
2026-04-1413GWubin Panindividual6.0M9.6%2026-04-14
2026-04-1413GBioFortune Inccorporation6.0M9.5%2026-04-14
2026-04-0113D/Ano. 5James Huangindividual13.2M21.2%2026-03-31
2026-04-0113D/Ano. 5Panacea Innovation Limitedcorporation13.2M21.2%2026-03-31
2026-04-0113D/Ano. 5Panacea Venture Healthcare Fund II, L.P.partnership13.2M21.2%2026-03-31
2026-04-0113D/Ano. 5Panacea Venture Healthcare Fund II GP Company, Ltd.corporation13.2M21.2%2026-03-31
2026-02-1713G/Ano. 4Zheng Weiindividual5.0M9.0%2025-12-31

13F holders

Tracked managers holding CNTB at their latest 13F. JSON

3 of the 30 tracked managers held CNTB at their latest 13F, $786K in total at quarter-end prices. Two Sigma Investments is the largest at $475K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 2 cut.

FundQuarterSharesValueOf portfolioChange in shares
Two Sigma Investments2026-06-30199K$475K0.00%+152K
Renaissance Technologies2026-06-3087K$208K0.00%-33K
Millennium Management2026-06-3044K$104K0.00%-431K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Connect Biopharma Holdings in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Connect Biopharma Holdings (CNTB), SEC CIK 1835268, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2025-11-24.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-06.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-12.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-30.JSON and CSV
Company record
EDGAR filing index for CIK 1835268Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of CNTB is sold short?
3,857,756 shares were held short at the 2026-10-15 settlement, 1.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is CNTB's daily short volume?
On 2026-11-02, 155,440 of the 300,394 CNTB shares reported to FINRA were sold short, 51.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does CNTB have fails to deliver?
The SEC's latest file shows 25 CNTB shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are CNTB insiders buying or selling?
No open-market insider trades were reported for CNTB in the last 90 days. The most recent filings are listed below. Latest filing: LIU JEAN I (Director) on 2026-09-30.
Have CNTB insiders filed to sell?
4 Form 144 notices on file for CNTB worth $9.6M at the prices reported; 0 in the last 90 days worth $0. Latest: Panacea Innovation Limited filed on 2025-11-24 to sell 2,000,000 shares ($6.0M) from 2025-11-24.
Who owns 5% or more of CNTB?
11 holders report 5% or more of CNTB in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is James Huang at 21.2% of the class (13,160,000 shares), filed 2026-04-01 for an event on 2026-03-31.
Which tracked 13F managers own CNTB?
3 of the 30 tracked 13F managers held CNTB shares at their latest filing, $786K in all. The largest: Two Sigma Investments (199K shares, $475K), Renaissance Technologies (87K shares, $208K), Izzy Englander's Millennium Management (44K shares, $104K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.